Literature DB >> 15155645

Association of type 2 cytokines with hepatic fibrosis in human Schistosoma mansoni infection.

Amélia Ribeiro de Jesus1, Andréa Magalhães, Delfin Gonzalez Miranda, Roberval Gonzalez Miranda, Maria Ilma Araújo, Adriana Almeida de Jesus, Angela Silva, Luciana B Santana, Edward Pearce, Edgar M Carvalho.   

Abstract

The objective of this study was to evaluate the role of cytokines in hepatic fibrosis in the prehepatosplenic and early hepatosplenic stages of schistosomiasis mansoni. Hepatic fibrosis was classified by ultrasonography of 94 patients. Immunological evaluation was performed by the measurement of secreted cytokines (interleukin-5 [IL-5], IL-10, IL-13, gamma interferon, tumor necrosis factor alpha, and transforming growth factor beta) in peripheral blood mononuclear cells (PBMC) stimulated by Schistosoma mansoni antigens. Significantly, higher levels of IL-5, IL-10, and IL-13 were found in supernatants of soluble egg antigen-stimulated PBMC from subjects with degree III hepatic fibrosis compared to patients with degree I or II fibrosis. Significant increases in IL-5 and IL-13 levels were also observed in some of the subjects who remained untreated for 1 year following initial assessment and developed more serious fibrosis during this period. The data suggest a role for type 2 cytokines in hepatic fibrosis in human schistosomiasis mansoni.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15155645      PMCID: PMC415716          DOI: 10.1128/IAI.72.6.3391-3397.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  Human immune responses to Schistosoma mansoni vaccine candidate antigens.

Authors:  A Ribeiro de Jesus; I Araújo; O Bacellar; A Magalhães; E Pearce; D Harn; M Strand; E M Carvalho
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

2.  Morbidity associated with Schistosoma mansoni infection determined by ultrasound in an endemic area of Brazil, Caatinga do Moura.

Authors:  A R De Jesus; D G Miranda; R G Miranda; I Araújo; A Magalhães; M Bacellar; E M Carvalho
Journal:  Am J Trop Med Hyg       Date:  2000 Jul-Aug       Impact factor: 2.345

3.  Serological responses among individuals in areas where both schistosomiasis and malaria are endemic: cross-reactivity between Schistosoma mansoni and Plasmodium falciparum.

Authors:  Cynthia W A Naus; Frances M Jones; Mohamed Z Satti; Sarah Joseph; Eleanor M Riley; Gachuhi Kimani; Joseph K Mwatha; Curtis H Kariuki; John H Ouma; Narcis B Kabatereine; Birgitte J Vennervald; David W Dunne
Journal:  J Infect Dis       Date:  2003-04-02       Impact factor: 5.226

4.  Clinical and immunologic evaluation of 31 patients with acute schistosomiasis mansoni.

Authors:  Amelia Ribeiro de Jesus; Angela Silva; Luciana B Santana; Andrea Magalhães; Adriana Almeida de Jesus; Roque Pacheco de Almeida; Marco A V Rêgo; Marcelo N Burattini; Edward J Pearce; Edgar M Carvalho
Journal:  J Infect Dis       Date:  2001-12-14       Impact factor: 5.226

5.  An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response.

Authors:  M G Chiaramonte; D D Donaldson; A W Cheever; T A Wynn
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

6.  Studies of murine schistosomiasis reveal interleukin-13 blockade as a treatment for established and progressive liver fibrosis.

Authors:  M G Chiaramonte; A W Cheever; J D Malley; D D Donaldson; T A Wynn
Journal:  Hepatology       Date:  2001-08       Impact factor: 17.425

7.  The role of TGF-beta 1 in mice hepatic fibrosis by Schistosomiasis Japonica.

Authors:  H Zhu; L Zeng; D Zhu; Y Yuan
Journal:  J Tongji Med Univ       Date:  2000

Review 8.  The pathophysiology of falciparum malaria.

Authors:  Ian A Clark; William B Cowden
Journal:  Pharmacol Ther       Date:  2003-08       Impact factor: 12.310

9.  Cytokine regulation of periportal fibrosis in humans infected with Schistosoma mansoni: IFN-gamma is associated with protection against fibrosis and TNF-alpha with aggravation of disease.

Authors:  Sandrine Henri; Christophe Chevillard; Adil Mergani; Patricia Paris; Jean Gaudart; Christophe Camilla; Hélia Dessein; Felix Montero; Nasr-Eldin M A Elwali; Osman K Saeed; Mubarak Magzoub; Alain J Dessein
Journal:  J Immunol       Date:  2002-07-15       Impact factor: 5.422

10.  Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune response.

Authors:  Monica G Chiaramonte; Margaret Mentink-Kane; Bruce A Jacobson; Allen W Cheever; Matthew J Whitters; Mary E P Goad; Anthony Wong; Mary Collins; Debra D Donaldson; Michael J Grusby; Thomas A Wynn
Journal:  J Exp Med       Date:  2003-03-17       Impact factor: 14.307

View more
  42 in total

Review 1.  The WHO ultrasonography protocol for assessing hepatic morbidity due to Schistosoma mansoni. Acceptance and evolution over 12 years.

Authors:  Tarik el Scheich; Martha C Holtfreter; Hendrik Ekamp; Daman D Singh; Rodrigo Mota; Christoph Hatz; Joachim Richter
Journal:  Parasitol Res       Date:  2014-09-27       Impact factor: 2.289

2.  Cytokine patterns in experimental schistosomiasis mansoni infected mice treated with silymarin.

Authors:  Nagwa Mostafa El-Sayed; Ghada Mahmoud Fathy; Sara Abdel-Rahman Abdel-Rahman; Mahmoud Abdel-Atei El-Shafei
Journal:  J Parasit Dis       Date:  2014-10-30

3.  Recombinant Sj16 from Schistosoma japonicum contains a functional N-terminal nuclear localization signal necessary for nuclear translocation in dendritic cells and interleukin-10 production.

Authors:  Xi Sun; Fan Yang; Jia Shen; Zhen Liu; Jinyi Liang; Huanqin Zheng; Mingchiu Fung; Zhongdao Wu
Journal:  Parasitol Res       Date:  2016-09-17       Impact factor: 2.289

4.  Experimental infection with Schistosoma mansoni in CCR5-deficient mice is associated with increased disease severity, as CCR5 plays a role in controlling granulomatous inflammation.

Authors:  Adriano L S Souza; Patrícia R S Souza; Cíntia A Pereira; Adriana Fernandes; Rodrigo Guabiraba; Remo C Russo; Leda Q Vieira; Ary Corrêa; Mauro M Teixeira; Deborah Negrão-Corrêa
Journal:  Infect Immun       Date:  2011-01-24       Impact factor: 3.441

Review 5.  Helminth infections and host immune regulation.

Authors:  Henry J McSorley; Rick M Maizels
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

6.  Schistosome egg antigens elicit a proinflammatory response by trophoblast cells of the human placenta.

Authors:  Emily A McDonald; Jonathan D Kurtis; Luz Acosta; Fusun Gundogan; Surendra Sharma; Sunthorn Pond-Tor; Hai-Wei Wu; Jennifer F Friedman
Journal:  Infect Immun       Date:  2012-12-17       Impact factor: 3.441

7.  IL-10 and TGF-beta redundantly protect against severe liver injury and mortality during acute schistosomiasis.

Authors:  De'Broski R Herbert; Tatyana Orekov; Charles Perkins; Fred D Finkelman
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

8.  Hepatic stellate cells and parasite-induced liver fibrosis.

Authors:  Barrie Anthony; Jeremy T Allen; Yuesheng S Li; Donald P McManus
Journal:  Parasit Vectors       Date:  2010-07-21       Impact factor: 3.876

9.  Regulatory role of interleukin-10 and interferon-gamma in severe hepatic central and peripheral fibrosis in humans infected with Schistosoma japonicum.

Authors:  Violaine Arnaud; Jun Li; Yuanyuan Wang; Xiao Fu; Shi Mengzhi; Xinsong Luo; Xunya Hou; Helia Dessein; Zhou Jie; Yu Xin-Ling; Hongbin He; Donald P McManus; Yuesheng Li; Alain Dessein
Journal:  J Infect Dis       Date:  2008-08-01       Impact factor: 5.226

10.  Enhanced protection from fibrosis and inflammation in the combined absence of IL-13 and IFN-γ.

Authors:  Thirumalai R Ramalingam; Richard L Gieseck; Thomas H Acciani; Kevin M Hart; Allen W Cheever; Margaret M Mentink-Kane; Kevin M Vannella; Thomas A Wynn
Journal:  J Pathol       Date:  2016-06-10       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.